Conning Inc. Abbott Laboratories Transaction History

Conning Inc.

$2.67 Billion
Q4 2024

A detailed history of Conning Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Conning Inc. holds 323,701 shares of ABT stock, worth $41.4 Million. This represents 1.37% of its overall portfolio holdings.

Number of Shares

323,701

Previous 331,533 2.36%

Holding current value

$41.4 Million

Previous $37.8 Million 3.14%

% of portfolio

1.37%

Previous 1.31%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 28, 2025	SELL	$111.93 - $119.39 $876,635 - $935,062	-7,832 Reduced 2.36%	323,701 $36.6 Million
Q3 2024 Oct 29, 2024	SELL	$100.07 - $118.13 $1.37 Million - $1.62 Million	-13,684 Reduced 3.96%	331,533 $37.8 Million
Q2 2024 Jul 26, 2024	BUY	$100.73 - $112.44 $4.09 Million - $4.57 Million	40,634 Added 13.34%	345,217 $35.9 Million
Q1 2024 Apr 26, 2024	BUY	$109.52 - $120.96 $335,021 - $370,016	3,059 Added 1.01%	304,583 $34.6 Million
Q4 2023 Jan 29, 2024	SELL	$90.19 - $110.4 $2.81 Million - $3.44 Million	-31,131 Reduced 9.36%	301,524 $33.2 Million
Q3 2023 Oct 26, 2023	BUY	$95.53 - $114.62 $839,613 - $1.01 Million	8,789 Added 2.71%	332,655 $32.2 Million
Q2 2023 Jul 21, 2023	SELL	$100.78 - $112.29 $1.64 Million - $1.83 Million	-16,258 Reduced 4.78%	323,866 $35.3 Million
Q1 2023 Apr 27, 2023	BUY	$96.86 - $114.01 $1.24 Million - $1.45 Million	12,759 Added 3.9%	340,124 $34.4 Million
Q4 2022 Feb 07, 2023	SELL	$95.06 - $111.52 $381,760 - $447,864	-4,016 Reduced 1.21%	327,365 $35.9 Million
Q3 2022 Oct 28, 2022	BUY	$96.76 - $112.03 $48,089 - $55,678	497 Added 0.15%	331,381 $32 Million
Q2 2022 Jul 20, 2022	BUY	$102.07 - $123.37 $586,290 - $708,637	5,744 Added 1.77%	330,884 $35.9 Million
Q1 2022 May 02, 2022	SELL	$114.02 - $139.04 $962,784 - $1.17 Million	-8,444 Reduced 2.53%	325,140 $38.5 Million
Q4 2021 Jan 27, 2022	SELL	$115.53 - $141.46 $1.03 Million - $1.26 Million	-8,886 Reduced 2.59%	333,584 $46.9 Million
Q3 2021 Nov 05, 2021	BUY	$116.66 - $129.06 $30.1 Million - $33.3 Million	258,400 Added 307.36%	342,470 $40.4 Million
Q2 2021 Jul 29, 2021	BUY	$105.79 - $124.53 $1.08 Million - $1.27 Million	10,237 Added 13.87%	84,070 $9.75 Million
Q1 2021 Apr 23, 2021	BUY	$108.84 - $128.23 $5.35 Million - $6.3 Million	49,139 Added 198.99%	73,833 $8.85 Million
Q4 2020 Jan 28, 2021	SELL	$105.0 - $114.42 $45,150 - $49,200	-430 Reduced 1.71%	24,694 $2.7 Million
Q3 2020 Oct 21, 2020	BUY	$91.64 - $111.29 $36,656 - $44,516	400 Added 1.62%	25,124 $2.73 Million
Q2 2020 Aug 07, 2020	SELL	$76.57 - $98.0 $109,265 - $139,846	-1,427 Reduced 5.46%	24,724 $2.26 Million
Q1 2020 Apr 29, 2020	SELL	$62.82 - $91.86 $29,148 - $42,623	-464 Reduced 1.74%	26,151 $2.06 Million
Q4 2019 Jan 29, 2020	BUY	$78.51 - $87.4 $73,799 - $82,156	940 Added 3.66%	26,615 $2.31 Million
Q3 2019 Oct 30, 2019	SELL	$81.84 - $88.74 $14,649 - $15,884	-179 Reduced 0.69%	25,675 $2.15 Million
Q2 2019 Jul 25, 2019	SELL	$72.88 - $85.0 $1.44 Million - $1.68 Million	-19,742 Reduced 43.3%	25,854 $2.17 Million
Q1 2019 Apr 22, 2019	BUY	$66.22 - $80.06 $64,167 - $77,578	969 Added 2.17%	45,596 $3.65 Million
Q4 2018 Jan 29, 2019	SELL	$65.56 - $74.27 $229,394 - $259,870	-3,499 Reduced 7.27%	44,627 $3.23 Million
Q3 2018 Oct 26, 2018	SELL	$60.81 - $73.36 $87,627 - $105,711	-1,441 Reduced 2.91%	48,126 $3.53 Million
Q2 2018 Jul 25, 2018	SELL	$57.57 - $63.54 $81,749 - $90,226	-1,420 Reduced 2.79%	49,567 $3.02 Million
Q1 2018 May 04, 2018	SELL	$56.27 - $63.62 $564,388 - $638,108	-10,030 Reduced 16.44%	50,987 $3.06 Million
Q4 2017 Jan 30, 2018	BUY	$53.68 - $57.47 $486,340 - $520,678	9,060 Added 17.44%	61,017 $3.48 Million
Q3 2017 Oct 20, 2017	BUY	$48.06 - $53.64 $2.5 Million - $2.79 Million	51,957	51,957 $2.77 Million

Others Institutions Holding ABT

# of Institutions

3,224

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $224B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Conning Inc., based on Form 13F filings with the SEC.

News

Stay updated on Conning Inc. with notifications on news.

Account